Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
XHANCE met both co-primary endpoints in the ReOpen1 trial, demonstrating statistically significant benefits on symptoms and CT scans…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Mar 22
XHANCE met both co-primary endpoints in the ReOpen1 trial, demonstrating statistically significant benefits on symptoms and CT scans…
16 Feb 22
Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals
15 Feb 22
Lungpacer has designed its AeroPace system to stimulate the nerves that activate the diaphragm to strengthen independent breathing
09 Feb 22
HeroTracker Sense is a next generation metered-dose inhaler (MDI) add-on connected device, which will help to address patient…
09 Feb 22
RheOx is a new system that endoscopically delivers non-thermal pulsed electric field (PEF) energy to the lung airways…
07 Feb 22
This decision is based on the receipt of reports that some bellavista 1000 and 1000e ventilators have unintentionally…
03 Feb 22
ZEPHYRx is a health information technology innovator, that quickly become an industry leader in RPM solutions for respiratory…
28 Jan 22
Lung Armor consists of Lung Cleanser that helps in clearance of trapped harmful substances like viruses, bacteria, dirt…
03 Jan 22
SleepX's solutions are developed using a portfolio of AI and sensing technologies for the tracking, analysis, and diagnosis…
13 Dec 21
The agreement to target $108m for Inspira Technologies over a seven-year period, subject to regulatory approvals